A majority of Americans are aware of the damage being done by this disastrous administration to our governing institutions, the rule of law, and the economy. I think far fewer are aware of the thousands of preventable deaths caused by Trump’s version of “policy.”
The most visible are those caused by the defunding of USAID. USAID funding helped save an estimated 91 million lives over the past 20 years. Now, a peer-reviewed study tells us that Trump’s defunding of the agency will lead to more than 14 million preventable deaths globally by 2030, a number that includes more than 4.5 million children under the age of five.
Far less visible–but equally horrific– are the likely consequences of Trump’s indiscriminate war on medical science, and his termination of grants supporting clinical trials. A recent article from the Washington Post explored those terminations. Citing research published in JAMA Internal Medicine, the article reported that funding for 383 clinical trials had been pulled, and that the funding disruptions affected more than 74,000 trial participants. The researchers found that the cuts disproportionately affected trials focused on infectious diseases (such as covid-19 and HIV); prevention; and behavioral interventions. More than 100 of the canceled grants supported cancer research.
Robert Hopkins, medical director for the National Foundation for Infectious Diseases, said the study showed that funding cuts disproportionately hit areas “that are critical to public health.”
Some of the clinical trials that lost their grants sued, and several got their funding back, but they experienced delays during the course of the trials that are likely to have significant negative impacts on the studies and on their participants. As one researcher explained, “If you pause an experiment, especially when it comes to experiments involving drugs and patients where you need a consistent dose over time and consistent measurements, it’s possible that you just screwed up the entire research.” Another noted that much of the clinical infrastructure was crippled or entirely destroyed during the grant terminations, making it very difficult to resume the research.
And of course, when clinical trials are delayed or canceled, the patients who were enrolled often lose access to care.
The funding terminations weren’t limited to clinical trials; numerous other research studies also lost funding. A study published in JAMA Internal Medicine in May found that between February and April, nearly 700 NIH grants had been terminated across 24 of the federal agency’s 26 institutes and centers. (It shouldn’t come as a surprise that studies focused on minorities–especially those investigating health concerns of non-Whites and LGBTQ+ citizens–appear to have been disproportionately targeted.)
Some of the greatest advancements made through research include vaccines, insulin, anesthesia, and treatments for infectious diseases. From laboratory studies to clinical trials and epidemiological investigations, scientists around the world use different methods of research to advance disease treatment, enhance diagnostics, and improve our overall understanding of diseases.
“Research is the key to advancing health on the individual, community, national, and global level,” said Cora Cunningham, PIH Engage member, Harvard T.H. Chan School of Public Health student, and research assistant with the Lantagne Group at Tufts University. “Whether about drinking water quality, disease dynamics, health systems, or the patient experience, research in public and global health is what allows us to access, receive, or deliver quality and patient-centered health care.”
Without research, there would be no breakthroughs, no clinical advancements, and no new cures. Despite its importance to humankind, biomedical research—particularly research funded through the National Institutes of Health (NIH)—has been targeted by the current U.S. administration.
The bottom line is that years of progress in public health have been disrupted. Thanks to a combination of frozen funding, the erection of new, onerous roadblocks to financing, and imposition of overly complicated new procedures, experts predict that the setbacks in research will cause generations of delays in breakthroughs and cures. As the linked article from Partners in Health warns, “patients who were part of clinical trials will face health risks due to the abrupt end to their treatment and support. Advancements made on cures and treatments for various diseases will be squandered. Jobs will be lost, and public health will suffer.”
The question is: why? This particular vendetta wasn’t a response to citizen demands. It isn’t even likely to line the pockets of the billionaires to whom this administration disproportionately caters. Like the destruction of USAID, it is simply gratuitously cruel.
Like Trump.
